Published in Neuroendocrinology on July 01, 1998
Food reinforcement and eating: a multilevel analysis. Psychol Bull (2007) 2.32
Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol (2008) 1.84
Modulation of food reward by adiposity signals. Physiol Behav (2006) 1.65
Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status. Am J Physiol Regul Integr Comp Physiol (2007) 1.49
Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol (2007) 1.48
Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am J Physiol Regul Integr Comp Physiol (2008) 1.28
Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci (2010) 1.25
Energy regulatory signals and food reward. Pharmacol Biochem Behav (2010) 1.25
Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats. Eur J Pharmacol (2008) 1.18
High fat diet and food restriction differentially modify the behavioral effects of quinpirole and raclopride in rats. Eur J Pharmacol (2009) 1.07
You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists. Neuropharmacology (2012) 1.04
Insulin signaling and addiction. Neuropharmacology (2011) 1.04
Influence of body weight and type of chow on the sensitivity of rats to the behavioral effects of the direct-acting dopamine-receptor agonist quinpirole. Psychopharmacology (Berl) (2011) 1.03
Ghrelin increases the motivation to eat, but does not alter food palatability. Am J Physiol Regul Integr Comp Physiol (2012) 0.99
Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. J Pharmacol Exp Ther (2006) 0.97
Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun (2015) 0.94
Leptin promotes dopamine transporter and tyrosine hydroxylase activity in the nucleus accumbens of Sprague-Dawley rats. J Neurochem (2010) 0.93
Eating high fat chow decreases dopamine clearance in adolescent and adult male rats but selectively enhances the locomotor stimulating effects of cocaine in adolescents. Int J Neuropsychopharmacol (2015) 0.90
Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism. J Neurosci (2012) 0.88
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev (2015) 0.88
Alterations in blood glucose levels under hyperinsulinemia affect accumbens dopamine. Physiol Behav (2006) 0.86
The adenosine A2A receptor agonist, CGS-21680, blocks excessive rearing, acquisition of wheel running, and increases nucleus accumbens CREB phosphorylation in chronically food-restricted rats. Brain Res (2007) 0.85
Importance of cholesterol in dopamine transporter function. J Neurochem (2012) 0.85
Dopamine Genetics and Function in Food and Substance Abuse. J Genet Syndr Gene Ther (2013) 0.84
Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. ACS Chem Neurosci (2010) 0.83
The hormonal signature of energy deficit: Increasing the value of food reward. Mol Metab (2013) 0.83
Endocrine links between food reward and caloric homeostasis. Appetite (2008) 0.83
A role for dopamine D1-like receptors in acute food deprivation-induced reinstatement of heroin seeking in rats. Int J Neuropsychopharmacol (2008) 0.83
Behavioral effects of amphetamine in streptozotocin-treated rats. Eur J Pharmacol (2007) 0.82
Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice. Genes Brain Behav (2013) 0.81
Restricted access to standard or high fat chow alters sensitivity of rats to the 5-HT(2A/2C) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. Behav Pharmacol (2014) 0.81
Central manipulation of dopamine receptors attenuates the orexigenic action of ghrelin. Psychopharmacology (Berl) (2013) 0.80
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease. Front Aging Neurosci (2016) 0.79
Human dopamine transporter gene: differential regulation of 18-kb haplotypes. Pharmacogenomics (2013) 0.79
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters. Pharmacol Rev (2016) 0.78
Acute fasting increases somatodendritic dopamine release in the ventral tegmental area. J Neurophysiol (2015) 0.77
Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction. Psychopharmacology (Berl) (2014) 0.77
Changes in dopamine transporter binding in nucleus accumbens following chronic self-administration cocaine: heroin combinations. Synapse (2014) 0.77
Effect of streptozotocin-induced diabetes on performance on a progressive ratio schedule. Psychopharmacology (Berl) (2014) 0.76
Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron (2001) 2.24
Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev (1992) 2.03
Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology (1992) 1.65
Obesity, diabetes and the central nervous system. Diabetologia (1998) 1.62
Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J Neurosci (1994) 1.27
Insulin in the brain. Annu Rev Physiol (1987) 1.23
Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab (1987) 1.22
D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem (1993) 1.17
Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res (1994) 1.12
The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev (1996) 1.09
PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat. Am J Physiol Regul Integr Comp Physiol (2001) 1.06
Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite (1986) 1.04
Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists? J Neurochem (1999) 1.04
Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res (1993) 1.03
Vasopressin in the septal area of the golden hamster controls scent marking and grooming. Physiol Behav (1990) 1.02
Developmental seizure susceptibility of kv1.1 potassium channel knockout mice. Dev Neurosci (1999) 1.01
NPY and food intake: discrepancies in the model. Regul Pept (1998) 1.00
Central insulin enhances sensitivity to cholecystokinin. Physiol Behav (1995) 1.00
Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats. Brain Res Bull (1998) 0.99
A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem Pharmacol (1992) 0.99
Insulin and insulin-like growth factors in the CNS. Trends Neurosci (1988) 0.98
Blockade of dopamine autoreceptors by haloperidol and the apparent dynamics of potassium-stimulated endogenous release of dopamine from and reuptake into striatal suspensions in the rat. Neuropharmacology (1992) 0.98
Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology (1998) 0.97
Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition. J Neurosci (2001) 0.96
Reduced effect of experimental peripheral hyperinsulinemia to elevate cerebrospinal fluid insulin concentrations of obese Zucker rats. Endocrinology (1987) 0.94
Localization of 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci Lett (1986) 0.93
PK 11195 antagonism of pyrethroid-induced proconvulsant activity. Eur J Pharmacol (1986) 0.93
Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res (1996) 0.92
Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res (1988) 0.91
Homeostatic control of ascorbate concentration in CNS extracellular fluid. Brain Res (1982) 0.91
Genetically obese Zucker rats have abnormally low brain insulin content. Life Sci (1985) 0.91
Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats. Peptides (2002) 0.89
Insulin and raclopride combine to decrease short-term intake of sucrose solutions. Peptides (2000) 0.89
Alpha(1) and beta(2) adrenoreceptor agonists inhibit pentylenetetrazole-induced seizures in mice lacking norepinephrine. J Pharmacol Exp Ther (2001) 0.89
Serotonergic lesioning differentially affects presynaptic and postsynaptic 5-HT1B receptor mRNA levels in rat brain. Brain Res (1996) 0.88
Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat. Brain Res Bull (1993) 0.87
Electrochemical assay for brain ascorbate with ascorbate oxidase. Anal Chem (1982) 0.86
Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci (1998) 0.86
Genetic comparison of seizure control by norepinephrine and neuropeptide Y. J Neurosci (2001) 0.86
Effects of third intracerebroventricular injections of corticotropin-releasing factor (CRF) on ethanol drinking and food intake. Psychopharmacology (Berl) (1998) 0.86
Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain. Diabetes (1986) 0.86
Chronoamperometry in brain slices: quantitative evaluations of in vivo electrochemistry. Brain Res (1983) 0.85
Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis. Diabetologia (2009) 0.85
Behavioral effects of persistent lymphocytic choriomeningitis virus infection in mice. Behav Neural Biol (1994) 0.85
A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine. J Neurochem (1997) 0.84
Relationships between the catechol substrate binding site and amphetamine, cocaine, and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro. J Neurochem (1998) 0.84
Learned helplessness increases 5-hydroxytryptamine1B receptor mRNA levels in the rat dorsal raphe nucleus. Biol Psychiatry (1997) 0.84
Kinetics of 65zinc uptake and distribution in fractions from cultured rat islets of langerhans. Diabetes (1980) 0.83
Insulin binding in the hypothalamus of lean and genetically obese Zucker rats. Peptides (1990) 0.83
Identification of binding sites for an insulin-like growth factor (IGF-I) in the median eminence of the rat brain by quantitative autoradiography. Endocrinology (1986) 0.83
Effects of repetitive hypoglycemia on neuroendocrine response and brain tyrosine hydroxylase activity in the rat. Stress (2002) 0.83
Rotating disk electrode voltammetric measurements of dopamine transporter activity: an analytical evaluation. Anal Biochem (1998) 0.82
In vivo voltammetry--present electrodes and methods. Neuroscience (1988) 0.82
Kinetic evaluation of the commonality between the site(s) of action of cocaine and some other structurally similar and dissimilar inhibitors of the striatal transporter for dopamine. J Neurochem (1994) 0.82
Immunoreactive insulin levels are elevated in the cerebrospinal fluid of genetically obese Zucker rats. Endocrinology (1983) 0.82
Neurotensin binding to dopamine. J Neurochem (1990) 0.82
Insulin stimulates membrane phospholipid metabolism by enhancing endogenous alpha 1-adrenergic activity in the rat hippocampus. Brain Res (1991) 0.82
Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure. Exp Neurol (2012) 0.81
Tyrosine hydroxylase mRNA is increased in old age and norepinephrine uptake transporter mRNA is decreased in middle age in locus coeruleus of Brown-Norway rats. Brain Res (1999) 0.81
Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations. Methods Enzymol (1998) 0.81
Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat. Neuropharmacology (1985) 0.81
Sodium depletion and aldosterone decrease dopamine transporter activity in nucleus accumbens but not striatum. Am J Physiol (1999) 0.80
Development of a model of status epilepticus in pigtailed macaque infant monkeys. Dev Neurosci (1999) 0.80
Repeated cocaine and stress increase dopamine clearance in the rat medial prefrontal cortex. Brain Res (1997) 0.80
Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons. Am J Physiol (1986) 0.80
Striatal transporter for dopamine: catechol structure-activity studies and susceptibility to chemical modification. J Neurochem (1994) 0.80
Morphological plasticity in an infant monkey model of temporal lobe epilepsy. Epilepsia (2000) 0.80
Vasopressin receptors in the brain, liver and kidney of rats following osmotic stimulation. Brain Res (1991) 0.79
Kindling with clozapine: behavioral and molecular consequences. Epilepsy Res (1996) 0.79
Intraventricular neuropeptide Y does not stimulate food intake in the baboon. Physiol Behav (1996) 0.79
Regulation of vasopressin receptors and phosphoinositide hydrolysis in the septum of heterozygous and homozygous Brattleboro rats. Neuroendocrinology (1989) 0.78
Insulin stimulates inositol incorporation in hippocampus of lean but not obese Zucker rats. Physiol Behav (1990) 0.78
65Zinc and endogenous zinc content and distribution in islets in relationship to insulin content. Endocrinology (1984) 0.78
Changes in 5-HT(7) serotonin receptor mRNA expression with aging in rat brain. Brain Res Mol Brain Res (2000) 0.78
Brain and liver insulin binding is decreased in Zucker rats carrying the 'fa' gene. Endocrinology (1985) 0.78
Increased insulin responsiveness in endotoxicosis. Circ Shock (1979) 0.78
Temporal relationship between neurotransmitter release and ion flux during spreading depression and anoxia. Can J Physiol Pharmacol (1987) 0.78
Evidence for a subtype of insulin-like growth factor I receptor in brain. Regul Pept (1986) 0.78
Studies of the mechanism of inhibition of the dopamine uptake carrier by cocaine in vitro using rotating disk electrode voltammetry. Ann N Y Acad Sci (1992) 0.78
Vasopressin-induced sensitization: involvement of neurohypophyseal peptide receptors. Eur J Pharmacol (1995) 0.77
Multisubtrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine. Synapse (1999) 0.77
Brain insulin binding is decreased in Wistar Kyoto rats carrying the 'fa' gene. Peptides (1986) 0.77
Dexamethasone antagonism of glucose dyshomeostasis in endotoxin shock. Circ Shock (1978) 0.77
Effect of exogenous zinc on insulin secretion in vitro. Endocrinology (1981) 0.77
Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.77
Insulin, neuropeptide Y, and food intake. Ann N Y Acad Sci (1993) 0.77
Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells. Brain Res Bull (1999) 0.77
Chronic alcohol consumption increases sensitivity to the anorexic effect of cholecystokinin. Am J Physiol (1993) 0.76
Effect of fasting interval on CCK-8 suppression of food intake in the baboon. Am J Physiol (1986) 0.76
[LeuB24]insulin is an insulin agonist at the liver in vivo. Am J Physiol (1983) 0.76
Neurotransmitter transporters: target for endocrine regulation. Horm Metab Res (1999) 0.76
Chronic hypoxia induces LLC-PK1 cell proliferation and dedifferentiation by the activation of protein kinase C. Am J Physiol (1997) 0.76
Sensitization with clozapine: beyond the dopamine hypothesis. Biol Psychiatry (1997) 0.75
Comments on the relation among GAD-65, IA-2 antibodies and body adiposity. Diabetologia (2000) 0.75
The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration. J Neurochem (1994) 0.75